皇冠体育寻求亚洲战略合作伙伴,皇冠代理招募中,皇冠平台开放会员注册、充值、提现、电脑版下载、APP下载。

首页社会正文

精彩足球推荐分析:KPJ Healthcare likely to post higher revenue

admin2022-09-1510

usdt支付对接(www.trc20.vip)是使用TRC-20协议的usdt支付对接平台,Usdt收款平台、Usdt自动充提平台。免费提供入金通道、Usdt钱包支付接口、Usdt自动充值接口、Usdt寄售回收。菜宝Usdt钱包一键生成Usdt钱包、一键调用API接口、一键出售Usdt。

PETALING JAYA: CGS-CIMB Research expects KPJ Healthcare Bhd to post higher revenue and core earnings per share (EPS) on a year-on-year (y-o-y) and quarter-on-quarter (q-o-q) basis in its upcoming second quarter results for financial year 2022 (2Q22).

This is based on a recent discussion with KPJ, which noted its patient volumes and bed occupancy rate (BOR) rose q-o-q in 2Q22.

“This is partly due to the impact of the Omicron Covid-19 variant, while we think revenue intensity should have also improved q-o-q on gradual fee hikes,” said CGS-CIMB Research in its latest report.

KPJ’s BOR also recovered to pre-pandemic levels of 66% to 67% at the end of May, it added.

The healthcare group’s health tourism (HT) revenue rose a robust 21% y-o-y in 1H22, albeit off a low base in 1H21 due to international border closures.

CGS-CIMB Research noted KPJ expects HT to form about 10% of its total revenue in FY22 and is set to grow 10% to 15% y-o-y in FY23.

Meanwhile, KPJ also projected cost savings from the centralisation of certain functions, such as procurement, credit facilities and management that were undertaken in the financial year 2021 to be offset by cost pressures for external service providers due to higher minimum wages in the near term.

,

精彩足球推荐分析www.99cx.vip)是一个开放皇冠体育网址代理APP下载、皇冠体育网址会员APP下载、皇冠体育网址线路APP下载、皇冠体育网址登录APP下载的官方平台。精彩足球推荐分析上足球分析专家数据更新最快。精彩足球推荐分析开放皇冠官方会员注册、皇冠官方代理开户等业务。

,

On the group’s earnings outlook, CGS-CIMB Research said: “We project FY22 core EPS to jump 95% y-o-y from the low base in FY21 before increasing a further 28.4% in FY23 and 10.3% y-o-y in FY24.”

It expects this to stem from rising patient volumes post-pandemic recovery, structurally higher private healthcare demand and growing health tourism contribution.

Other positive factors include improving revenue intensity, cost savings from the centralisation of certain functions, recovery in associate earnings and normalisation of effective tax rate in FY22.

In another development, KPJ’s plans to divest its loss-making Indonesia operations are progressing well and likely to be concluded by end-2022, said CGS-CIMB Research.

“However, the completion of the sale of Jeta Gardens (JT) may be delayed slightly to end-2023 from 3Q23 previously,” it added.

The research house noted KPJ for now intends to reinvest the cash proceeds from the sale of its Indonesian operations to ramp up capacity at Damansara Specialist Hospital 2, while it does not project material cash proceeds from the JT sale.

CGS-CIMB Research has upgraded the stock to an “add” call with a slightly higher target price of RM1.04.

It noted the re-rating catalysts for KPJ include full recovery from Covid-19, rising HT contribution and sale of its foreign operations.


转载说明:本文转载自Sunbet。

网友评论

1条评论

热门标签